Venous thrombotic events are not increased in patients with rheumatoid arthritis treated with anti-TNF therapy: results from the British Society for Rheumatology Biologics Register.
about
Cardiovascular outcomes and tumour necrosis factor antagonists in chronic inflammatory rheumatic disease: a focus on rheumatoid arthritis.Venous thrombosis and prothrombotic factors in inflammatory bowel disease.Possible association of etanercept, venous thrombosis, and induction of antiphospholipid syndrome.The British Society for Rheumatology Biologics Registers in Ankylosing Spondylitis (BSRBR-AS) study: Protocol for a prospective cohort study of the long-term safety and quality of life outcomes of biologic treatment.Rheumatoid Arthritis Does Not Increase Risk of Short-term Adverse Events after Total Knee Arthroplasty: A Retrospective Case-control Study.Prothrombotic effects of tumor necrosis factor alpha in vivo are amplified by the absence of TNF-alpha receptor subtype 1 and require TNF-alpha receptor subtype 2.Inflammatory bowel disease: epidemiology, pathology and risk factors for hypercoagulability.Drug-induced lupus anticoagulants and antiphospholipid antibodies.Autoimmune diseases and venous thromboembolism: a review of the literature.Unexpected hematologic effects of biotherapeutics in nonclinical species and in humans.Safety of synthetic and biological DMARDs: a systematic literature review informing the 2013 update of the EULAR recommendations for management of rheumatoid arthritis.Thromboembolic complications in inflammatory bowel disease.The relationship between coagulation state and inflammatory bowel disease: current understanding and clinical implications.Risk of venous thromboembolism in patients with rheumatoid arthritis: initiating disease-modifying antirheumatic drugs.The risk of pulmonary embolism and deep vein thrombosis in rheumatoid arthritis: a UK population-based outpatient cohort study.Detrimental roles of TNF-alpha in the antiphospholipid syndrome and de novo synthesis of antiphospholipid antibodies induced by biopharmaceuticals against TNF-alpha.Steroid but not biological therapy elevates the risk of venous thromboembolic events in inflammatory bowel disease. A meta-analysis.Drug safety and immunogenicity of tumour necrosis factor inhibitors: the story so far.The Impact of Biologics and Tofacitinib on Cardiovascular Risk Factors and Outcomes in Patients with Rheumatic Disease: A Systematic Literature Review.Short-term effect of infliximab is reflected in the clot lysis profile of patients with inflammatory bowel disease: a prospective study.
P2860
Q30240180-DF78B6DB-3716-47B5-9708-B5827DDFC16EQ33564092-732FA9F2-E36A-421D-A58F-B0453B7D0B39Q33737258-6D7C4EB2-44DF-4E2B-AF87-B4E225A17FAAQ35838797-38798B18-BFF3-4724-8FB0-9C47322AAD8AQ36588424-8218C400-8FCB-4709-8061-7AA64C86E215Q36633243-BB1FF484-68EC-4669-8D32-F50DAC2FA74FQ37454573-F3E9AA11-6523-484C-93F6-6369AC8F7832Q37967416-DBFAA079-F5BA-4694-91DB-0A0E2D1620FEQ38039441-1B0E84DD-1E2C-4940-ABC7-B908346BBE04Q38087506-C63047DD-CFE9-4C97-B5ED-E23DD96BC567Q38176745-812909E8-D6F9-4BB4-BBCD-7381F74B9209Q38239252-BE07E913-1237-466F-A55F-D2DF4E388960Q38365449-773B8DAD-2312-4E29-96DA-64AB3ED3F64EQ40091147-67369FFE-D007-4973-BF00-26B4451A67B9Q43488992-5E214124-6263-45DB-8EE1-52D77E131DA4Q48192268-1E44761C-AE94-4393-9535-E08DDE90843FQ50003119-44CBE52C-6949-4B3B-A5E7-4A62A48E88ABQ50083992-DC5C9CFF-78C2-43E3-BA68-A24404CBE097Q50109832-27849C87-A31E-4FB4-9BBF-2328D51D1746Q53617328-102E7445-B4BF-4A2A-B749-E6A547A2BADF
P2860
Venous thrombotic events are not increased in patients with rheumatoid arthritis treated with anti-TNF therapy: results from the British Society for Rheumatology Biologics Register.
description
2011 nî lūn-bûn
@nan
2011 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Venous thrombotic events are n ...... eumatology Biologics Register.
@ast
Venous thrombotic events are n ...... eumatology Biologics Register.
@en
type
label
Venous thrombotic events are n ...... eumatology Biologics Register.
@ast
Venous thrombotic events are n ...... eumatology Biologics Register.
@en
prefLabel
Venous thrombotic events are n ...... eumatology Biologics Register.
@ast
Venous thrombotic events are n ...... eumatology Biologics Register.
@en
P2093
P2860
P50
P356
P1476
Venous thrombotic events are n ...... heumatology Biologics Register
@en
P2093
BSRBR Control Centre Consortium, British Society for Rheumatology Biologics Register
Kath D Watson
Kimme L Hyrich
P2860
P304
P356
10.1136/ARD.2011.153536
P407
P577
2011-07-22T00:00:00Z